Compare the price of anything · Serving consumers and businesses across the UK
Ar gael yn GymraegAvailable in Welsh
Browse servicesFind businesses
List your business
Home›Health Medical›Drug Development and Testing
UK National Overview

Cost of Drug Development and Testing
across the UK

National price data for Drug Development and Testing based on estimated ranges across the UK. Compare regions, find local providers, and understand what affects the price.

–
National range
–
Average price
Estimated
Submissions
–
Regions with data
Compare prices in your area
Accreditation & credentials
Trade bodies & what they mean for Drug Development and Testing

# Drug Development and Testing Accreditation

In the UK, drug development and testing services are primarily regulated and accredited through several key bodies. The Medicines and Healthcare products Regulatory Agency (MHRA) is the statutory regulator and maintains oversight of clinical trials and pharmaceutical testing through its Clinical Trials Authorisation process. The Association of the British Pharmaceutical Industry (ABPI) represents pharmaceutical companies and maintains codes of conduct that member organisations must follow. For Contract Research Organisations (CROs) that conduct testing work, accreditation through the Quality Overall Summary (QOS) scheme or ISO 17025 for laboratory testing is common, demonstrating compliance with international standards. Some providers also seek accreditation from the British In Vitro Diagnostics Association (BIVDA) if they work with diagnostic testing. These accreditations indicate that a provider has met rigorous standards for quality, safety, and ethical conduct in their operations.

Verifying a provider's credentials is straightforward and essential before engaging their services. You can check MHRA registration status directly through their official website, which lists authorised clinical trial sponsors and investigator sites. For ABPI member status, the association publishes a searchable directory on their site. Request copies of relevant ISO certifications, Quality Overall Summary approvals, or other credentials directly from the provider, as legitimate accredited organisations are transparent about their qualifications. Ask for evidence of Good Laboratory Practice (GLP) compliance, Good Manufacturing Practice (GMP) certification, and relevant insurance coverage. Verification matters because it protects your organisation from legal liability, ensures data integrity and regulatory compliance, and confirms that the provider follows established protocols for safety and ethical standards in potentially sensitive testing environments.

Accredited providers typically charge 15 to 40 percent more than non-accredited competitors, depending on the complexity and regulatory requirements of the testing required. This premium reflects genuine cost

Common questions
Drug Development and Testing — frequently asked questions
How much does drug development and testing cost in the UK?
Drug development and testing in the UK typically costs between £500 million and £2.6 billion per drug. Costs vary significantly based on therapeutic area, trial complexity, regulatory requirements, and whether development occurs in-house or through contract research organisations. Early-stage research is substantially cheaper than late-phase clinical trials.
What affects the cost of drug development and testing?
Key cost factors include clinical trial phase (Phase I–IV), number of trial participants required, regulatory approval complexity, therapeutic indication type, manufacturing scale-up expenses, and post-market surveillance obligations. Geographic location of trials, specialist personnel requirements, and compliance with MHRA standards significantly impact overall expenditure throughout development.
What does a drug development and testing service actually include?
Services encompass preclinical laboratory testing, toxicology studies, formulation development, manufacturing process validation, clinical trial design and management, patient recruitment, data analysis, regulatory documentation preparation, MHRA submission support, and post-approval monitoring. Full-service providers offer integrated solutions from initial discovery through market launch and ongoing pharmacovigilance reporting.
What's the difference between preclinical and clinical drug testing?
Preclinical testing uses laboratory and animal models to assess drug safety and efficacy before human exposure. Clinical testing involves human trials across four phases to evaluate safety, dosage, efficacy, and adverse reactions. Clinical trials are substantially longer, more expensive, and require MHRA oversight, whilst preclinical studies establish foundational safety data.
What should I check before hiring a drug development and testing provider?
Verify MHRA accreditation, ICH-GCP compliance certification, and GLP (Good Laboratory Practice) credentials. Check previous trial success rates, regulatory approval history, and specialist expertise in your therapeutic area. Confirm insurance coverage, quality management systems, and membership with industry bodies like the Association of the British Pharmaceutical Industry.
How long does drug development and testing typically take in the UK?
Complete drug development averages ten to fifteen years from discovery to market launch. Preclinical testing requires three to six years; clinical trials span five to seven years across four phases. MHRA review adds twelve to twenty-four months. Timescales vary considerably depending on therapeutic indication complexity and regulatory requirements.
Does drug development require certified professional oversight in the UK?
Yes, drug development is heavily regulated. The MHRA mandates qualified personnel, including qualified persons, clinical trial sponsors, and pharmacovigilance experts. All clinical trials require regulatory authorisation and ethics committee approval. Providers must employ certified professionals meeting GCP standards. Non-compliance results in serious legal and financial penalties.

Know what you paid?

Help build UK price data for Drug Development and Testing. Takes 60 seconds.

Submit a priceList your business free
Data overview
National min–
National max–
SubmissionsEstimated
Regions covered–
Data statusEstimated
View methodology →
Related services
Prescription MedicinesSurgical InstrumentsResidential Rehabilitation ServicesOrthodontic TreatmentCosmetic Surgery
National price data sourced from business and consumer submissions across the UK. Regional averages are indicative. Methodology · Submit a price · List your business